Successful treatment of a VIPoma by continuous subcutaneous infusion of somatostatin analogue (SMS 201‐995)

SUMMARY A case with WDHA syndrome due to VIPoma is reported. Injection of somatostatin analogue SMS 201‐995 was followed by prompt suppression of vasoactive intestinal polypeptide levels (VIP), decreased stool volume, and restoration of the serum potassium concentration to normal. Long‐term treatmen...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Alimentary pharmacology & therapeutics 1988-06, Vol.2 (3), p.269-279
Hauptverfasser:	NIITSU, Y., GOTO, Y., MAEDA, M., TSUSHIMA, N., WATANABE, N., KOHGO, Y., URUSHIZAKI, I.
Format:	Artikel
Sprache:	eng
Schlagworte:	Female Humans Infusions, Intravenous Middle Aged Octreotide - administration & dosage Octreotide - therapeutic use Pancreatic Neoplasms - drug therapy Vipoma - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!